ArticleBMC genomics2025
Tissue-specific biosynthesis and spatial distribution of xanthones in Garcinia oblongifolia revealed by integrated metabolomic and full-length transcriptomic analyses.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe medicinal plant Garcinia oblongifolia (Clusiaceae), widely used in the Lingnan area of southern China, exhibits notable anti-inflammatory, analgesic, antimyatrophy, antibacterial, and antitumor properties. Traditional applications, particularly the use of its bark, were extensive and largely attributed to bioactive xanthones. However, the tissue-specific distribution and biosynthesis of these compounds remained poorly understood.
resultsMetabolite profiling identified 402 metabolites, including 215 that accumulated differentially across four tissues. Notably, 16 xanthones were predominantly localized in the bark and branches, with prenyl-substituted derivatives exhibiting the highest accumulation in branches. To elucidate xanthones biosynthesis, we integrated Illumina and single-molecule real-time (SMRT) sequencing, which yielded 70,401 full-length transcripts. Transcriptomic analysis revealed 8,842 differentially expressed transcripts, with xanthone-related genes showing bark-specific expression a pattern confirmed by qRT-PCR. We reconstructed a putative xanthone biosynthetic pathway involving 32 full-length transcripts encoding seven key enzymes. Phylogenetic and motif analyses revealed that four benzophenone synthase (BPS) homologs catalyze the conversion of benzoyl-CoA into 2,4,6-trihydroxybenzophenone. As a pivotal enzyme, BPS plays a central role in this biosynthetic pathway. Transcription factor analysis indicated that the bHLH family was closely associated with the regulation of BPS. Correlation and WGCNA analyses demonstrated a positive regulatory relationship between PAL, C4H, CoA-hydratase genes and their downstream metabolites. Notebly, BPS, XS, and PT genes were highly expressed in bark, while their corresponding metabolites accumulated in both bark and branches, suggesting inter-tissue translocation.
conclusionsOur study analyzed xanthone distribution in G. oblongifolia, supporting its medicinal uses, and provided its first full-length transcriptome. We proposed a xanthone biosynthetic pathway, aiding in vitro synthesis and sustainable production, advancing pharmacological and biotechnological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.